Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

Treatments and trials you qualify for
Education for your stage of care
Financial support for your medications
Solutions to your side effects

How Does an MPN Affect Women’s Health? Dr. Chi Joan How Explains

Name: How Does an MPN Affect Women’s Health? Dr. Chi Joan How Explains
Start: 2026-09-24T11:30:00-04:00
End: 2026-09-24T12:30:00-04:00

Sep 24, 2026

11:30AM - 12:30PM EDT

Online Event

Overview

Join the HealthTree Foundation for a vital discussion on how Myeloproliferative Neoplasms (MPNs) uniquely impact women at every stage of life. Renowned specialist Dr. Chi Joan How will explore essential topics, including symptom management, hormonal influences, reproductive health, and long-term wellness strategies tailored specifically for female patients. Whether you are navigating a new diagnosis or seeking clearer answers on managing daily life with an MPN, this webinar offers actionable insights to help you advocate for your health. Don't miss this opportunity to gain expert guidance and get your questions answered live.

Agenda

11:30 AM

Introductions

Dalton Bean

Dalton introduces the agenda of the event and featured speaker Dr. Chi Joan

11:35 AM

Presentation

Dr. Chi-Joan How

Dr. Chi-Joan How explains how women's health is affected by MPNs

12:05 PM

Questions & Answers

Audience

Bring your questions!

Speakers & Moderators

Dalton Bean

Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Dr. Chi-Joan How

Dr. Chi-Joan How is a hematologist specializing in myeloproliferative neoplasms (MPNs) at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, where she also serves as Clinical Chief of Hematology at Brigham and Women's Faulkner Hospital. She earned her undergraduate degree at Harvard College, her medical degree from Yale School of Medicine, and completed her hematology/oncology fellowship at Dana-Farber Cancer Institute. Dr. How is dedicated to advancing patient care and clinical research in rare blood disorders, with a specific focus on improving treatment strategies and quality of life for MPN patients.